Spear Therapeutics Overview
- Founded
-
2002
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
4
Spear Therapeutics General Information
Description
Developer of anti-cancer drugs. The company caters to the healthcare industry and specializes in developing prodrugs for the treatment of cancer.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Office
- Sardinia House
- 6th Floor
- London
- England, United Kingdom
Spear Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Spear Therapeutics Patents
Spear Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2009254176-A1 | 4, 6-diphenylpyrid-2-0nes against cancer | Inactive | 04-Jun-2008 | 0000000000 | |
| CA-2726939-A1 | 4,6-diphenylpyrid-2-ones against cancer | Inactive | 04-Jun-2008 | 0000000000 | |
| EP-2310370-A1 | 4, 6-diphenylpyrid-2-ones against cancer | Inactive | 04-Jun-2008 | 0000000000 | |
| GB-0810228-D0 | Novel compounds | Inactive | 04-Jun-2008 | 0000000000 | |
| JP-2011521986-A | 4,6-diphenylpyrid-2-one for cancer | Pending | 04-Jun-2008 | C07D213/64 |
Spear Therapeutics Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Gerry Potter | Co-Founder |
Spear Therapeutics Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|